1. Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

   • Steven L. Truong
   • Tim McEwan
   • Philip C. Robinson

   Guidelines Open access 28 December 2021 Pages: 1 - 24

   

2. The Economic Burden of Lupus Nephritis: A Systematic Literature Review

   • Juliette C. Thompson
   • Anadi Mahajan
   • Kerry Gairy

   Review Open access 03 November 2021 Pages: 25 - 47

   

3. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice

   • Sneha Patel
   • Anand Kumthekar

   Review Open access 19 November 2021 Pages: 49 - 71

4. Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

   • María Aparicio
   • Carlos A. Guillén-Astete
   • Fernando J. Rodríguez Martínez

   Review Open access 27 November 2021 Pages: 73 - 94

   

5. The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model

   • Sophie Cleanthous
   • Sara Strzok
   • Thomas Morel

   Original Research Open access 08 October 2021 Pages: 95 - 108

   

6. Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H

   • Lars-Erik Kristensen
   • Masato Okada
   • Kurt de Vlam

   Original Research Open access 28 October 2021 Pages: 109 - 125

   

7. The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study

   • Johannes Nossent
   • Charles Inderjeeth
   • Erin Kelty

   Original Research Open access 11 November 2021 Pages: 127 - 137

   

8. Comparative Effectiveness of Azathioprine Versus Cyclosporine as an Initial Treatment for Idiopathic Inflammatory Myopathies: A Population-Based Observational Study

   • Sun-Young Jung
   • Yoon-Kyoung Sung
   • Soo-Kyung Cho

   Original Research Open access 13 November 2021 Pages: 139 - 149

   

9. Burden, Treatment Patterns and Unmet Needs of Osteoarthritis in Dubai: a Retrospective Analysis of the Dubai Real-World Claims Database

   • Jamal A. Al-Saleh
   • Ali A. Albelooshi
   • Jean G. Joury

   Original Research Open access 16 November 2021 Pages: 151 - 174

   

10. Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study

    • Yanying Liu
    • Shengyun Liu
    • Zhanguo Li

    Original Research Open access 22 November 2021 Pages: 175 - 189

    

11. Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

    • Philip Conaghan
    • Stanley Cohen
    • Roy Fleischmann

    Original Research Open access 23 November 2021 Pages: 191 - 206

    

12. Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower^® Registry

    • W. Benjamin Nowell
    • Elaine Karis
    • Jeffrey R. Curtis

    Original Research Open access 28 November 2021 Pages: 207 - 221

    

13. Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis

    • Sebnem Ataman
    • Ismihan Sunar
    • Mehmet Tuncay Duruoz

    Original Research Open access 01 December 2021 Pages: 223 - 241

    

14. Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment

    • Kevin L. Winthrop
    • Jeffrey R. Curtis
    • Gerd R. Burmester

    Original Research Open access 06 December 2021 Pages: 243 - 263

    

15. Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings

    • Peter Hur
    • Esther Yi
    • Alexei A. Grom

    Original Research Open access 07 December 2021 Pages: 265 - 283

    

16. Usage of C-Reactive Protein Testing in the Diagnosis and Monitoring of Psoriatic Arthritis (PsA): Results from a Real-World Survey in the USA and Europe

    • A. Ogdie
    • W. Tillett
    • L. C. Coates

    Brief Report Open access 15 January 2022 Pages: 285 - 293

    

17. Seronegative Erosive Arthritis Following SARS-CoV-2 Infection

    • Alexandros A. Drosos
    • Eleftherios Pelechas
    • Paraskevi V. Voulgari

    Case Report Open access 16 November 2021 Pages: 295 - 301

    

18. Correction to: The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model

    • Sophie Cleanthous
    • Sara Strzok
    • Thomas Morel

    Correction Open access 10 November 2021 Pages: 303 - 303

19. Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19

    • Andrew J. Holman
    • Edward Keystone
    • Norman Gaylis

    Letter to the Editor Open access 10 November 2021 Pages: 305 - 307

20. A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study

    • Stanley Cohen
    • Viatcheslav R. Akmaev
    • Erin Connolly-Strong

    Letter to the Editor Open access 10 November 2021 Pages: 309 - 311